| Name | Title | Contact Details |
|---|---|---|
Bob Smith |
Chief Commercial Officer | Profile |
Danielle Wiener |
Associate Director, Clinical Supply Chain | Profile |
Mario Orlando |
VP, Commercial New Product Planning | Profile |
Annie Enriquez |
Associate Director, Human Resources and Talent Acquisition | Profile |
Faheem Hasnain |
Chairman and Chief Executive Officer | Profile |
For thousands of years, people have discovered medicines from fungi by brewery. This approach has led to transformative medicines that saved millions of lives and have altered the course of medical history. Drug discovery by brewery proved to be difficult and time-consuming, leaving the field in search of a disruptive technological solution. Our genomically-enabled drug discovery engine is precisely that solution, dramatically accelerating the search for nature’s breakthrough drugs. At LifeMine, genomicists, bioinformaticians and microbiologists identify new evolutionary solutions for disease intervention; natural products chemists access the natural molecules that inspire our drug discovery efforts; biologist and chemist drug hunters craft these into disruptively innovative medicines, and translational medical scientists bring the life-saving solutions forward into patients in need.
Crescent City Surgical Centre is a Metairie, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Diosynth is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Norgren Systems is a Ronceverte, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.